O'Loughlin Steve
Insider CIK 1615840 · ATNM Principal Financial Officer, Director · CNSP Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CNSP CNS Pharmaceuticals, Inc. | A Award deriv | 2026-03-02 | 2026-03-04 | 9,500 | — | $0 | 9,500 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 3,333 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 1,666 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 3,333 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 8,833 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 13,333 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 59,066 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 107,463 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 256,438 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 253,123 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2023-12-28 | 2023-12-29 | 253,123 | — | $0 | 253,123 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2022-07-01 | 2022-07-01 | 256,438 | — | $0 | 256,348 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2021-09-01 | 2021-09-03 | 107,463 | — | $0 | 107,463 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2020-08-12 | 2020-08-14 | 59,066 | — | $0 | 59,066 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2019-07-12 | 2019-07-16 | 400,000 | $0.23 | $92.0K | 400,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | P Buy | 2018-12-10 | 2018-12-10 | 10,000 | $0.44 | $4.4K | 35,500 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2018-07-13 | 2018-07-17 | 265,000 | $0.78 | $206.7K | 265,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | P Buy | 2018-06-15 | 2018-06-15 | 12,000 | $0.50 | $6.0K | 25,500 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | J Other deriv | 2018-03-06 | 2018-03-08 | 7,500 | $0.50 | $3.8K | 7,500 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | J Other deriv | 2018-03-06 | 2018-03-08 | 2,500 | $0.50 | $1.3K | 2,500 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | J Other | 2018-03-06 | 2018-03-08 | 10,000 | $0.50 | $5.0K | 13,500 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | P Buy | 2017-06-15 | 2017-06-15 | 3,500 | $1.17 | $4.1K | 3,500 | SEC↗ |